SCHIZOPHRENIA/ MENTAL DISORDERS

 

The Report of the National Commission on Marihuana and Drug Abuse Acute Effects of Marihuana       (full – 1972)  http://www.druglibrary.org/schaffer/library/studies/nc/nc1e.htm

 

radical notion                    (letter – 1974)

http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/1/11/16-  a?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=1040&res  ourcetype=HWCIT

 

Study Shows Long Term Marijuana Users Healthy                     (news – 1994)

http://www.erowid.org/plants/cannabis/cannabis_science3.shtml

 

Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.       (abst – 2000)                                            http://www.ncbi.nlm.nih.gov/pubmed/11204352

 

 Are Cannabinoid Receptor Knockout Mice Animal Models for Schizophrenia?

(abst – 2000)              http://www.medical-hypotheses.com/article/S0306-9877%2800%2991261-1/abstract

 

Cannabis Use is Not Associated with the Development of Psychosis in an ‘ultra’ High-risk Group.           (abst – 2002)               http://www.ncbi.nlm.nih.gov/pubmed/12406123

 

Tobacco and Cannabis Smoking Cessation Can Lead to Intoxication with Clozapine or Olanzapine.        (abst – 2002)                         http://www.ncbi.nlm.nih.gov/pubmed/11981356

 

Marijuana receptor gene abnormality in schizophrenia                (news – 2002)

http://www.eurekalert.org/pub_releases/2002-07/mp-mrg061802.php

 

Cannabis may treat psychiatric disorders                 (news – 2002)

http://www.highbeam.com/doc/1G1-90446996.html

 

Recipe For Trouble              (anecdotal/ news – 2002)

http://www.cbsnews.com/stories/2002/03/05/48hours/main503022.shtml

 

Cannabis and the brain.                   (full – 2003)

http://brain.oxfordjournals.org/cgi/content/full/126/6/1252

 

Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.                                               (full – 2003)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574061/?tool=pubmed

 

Endocannabinoid signalling in the blood of patients with schizophrenia (full – 2003)                                                  http://www.lipidworld.com/content/2/1/5

 

Aetiology – Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm                                                           (full – 2004)  http://ebmh.bmj.com/content/7/4/119.long

 

Cannabis as a psychotropic medication                (letter – 2004)

http://bjp.rcpsych.org/cgi/content/full/185/1/78

 

Lower Negative Symptom Scores Among Cannabis-dependent Patients with Schizophrenia-spectrum Disorders: Preliminary Evidence from an African American First-episode Sample.      (abst – 2004)

http://www.schres-journal.com/article/S0920-9964%2804%2900035-0/abstract

 

How our brains fend off madness, we produce a cannabis like substance            (news – 2004)

http://www.medicalnewstoday.com/releases/12516.php

 

Cannabis does not induce schizophrenia,  Dutch scientists say              (news – 2004)

http://www.medicalnewstoday.com/articles/12283.php

 

On the Cannabinoid Receptor: A Study in Molecular Psychiatry             (full – 2005)

http://www.torontohemp.com/phpBB3/viewtopic.php?f=7&t=152

 

 

Symptoms of schizotypy precede cannabis use.                (full – 2005)

http://socialsciences.people.hawaii.edu/publications_lib/Cannabis%20and%20SPD.pdf

 

Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in acute schizophrenia.                                                        (abst – 2005)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=171

 

Cannabis and schizophrenia link blurs further               (news – 2005)    (may need registration)  http://www.newscientist.com/channel/health/mg18624953.800-cannabis-and-schizophrenia-link-blurs-  further.html

 

Chemicals in Cannabis may help mentally ill                 (news – 2005)

http://www.news-medical.net/news/2005/06/06/10716.aspx

 

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.             (full – 2006)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-  879X2006000400001&lng=en&nrm=iso&tlng=en

 

Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction   (full – 2006)  http://www.ukcia.org/research/COMTgene.pdf

 

The Mental Health Risks of Adolescent Cannabis Use            (full – 2006)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1351917&tool=pmcentrez

 

Cannabis and psychosis              (letter – 2006)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360440&tool=pmcentrez

 

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. (abst – 2006)                                    http://www.ncbi.nlm.nih.gov/pubmed/16710682  

 

An Experimental Study of Catechol-O-Methyltransferase Val(158)Met Moderation of Delta-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition.

(abst – 2006)  http://www.unboundmedicine.com/medline/ebm/record/16936704/abstract/An_Experimental_Study_of_Ca  techol_O_Methyltransferase_Val_158_Met_Moderation_of_Delta_9_Tetrahydrocannabinol_Induced_Effe  cts_on_Psychosis_and_Cognition

 

Cannabis use does not cause schizophrenia                (news – 2006)

http://www.health.am/psy/more/cannabis_use_does_not_cause_schizophrenia/

 

No Increased Schizophrenia Risk With Use Of Cannabis              (news – 2006)  http://www.thehempire.com/index.php/cannabis/news/no_increased_schizophrenia_risk_with_use_of_cann abis

 

Cannabis is a First-Line Treatment for Childhood Mental Disorders

(news – 2006)               http://www.counterpunch.org/2006/07/08/cannabis-is-a-first-line-treatment-for-  childhood-mental-disorders/

 

Reefer Madness Refuted             (letter – 2007)    http://www.cmaj.ca/content/177/8/988.full.pdf+html

 

A Comparison of Symptoms and Family History in Schizophrenia with and Without Prior Cannabis Use: Implications for the Concept of Cannabis Psychosis.

(abst – 2007)

http://www.schres-journal.com/article/S0920-9964%2807%2900150-8/abstract

 

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use.                                        (abst – 2007)  http://www.unboundmedicine.com/medline/ebm/record/17566707/abstract/Anandamide_levels_in_cerebro spinal_fluid_of_first_episode_schizophrenic_patients:_Impact_of_cannabis_use

 

Cannabinoids and psychosis.               (abst – 2007)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=1734986  5&ordinalpos=185&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

 

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis (full – 2008)

http://bjp.rcpsych.org/cgi/content/full/192/4/306?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=ca  nnabinoid&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT

 

The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. (abst – 2008)                                     http://www.ncbi.nlm.nih.gov/pubmed/18666905

 

Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring.                                                       (full – 2009)  http://bjp.rcpsych.org/cgi/content/full/195/4/294

 

Cannabis and suicide: longitudinal study.               (full – 2009)

http://bjp.rcpsych.org/content/195/6/492.long

 

Parasitic brain infection, endocannabinoids, and schizophrenia.               (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/18995970/abstract/Parasitic_brain_infection_endoc  annabinoids_and_schizophrenia_

 

The role of cannabis in cognitive functioning of patients with schizophrenia. (abst – 2009)

http://www.unboundmedicine.com/medline/ebm/record/19326102/abstract/The_role_of_cannabis_in_cogni tive_functioning_of_patients_with_schizophrenia_

 

Cannabis use and deliberate self-harm in adolescence: a comparative analysis of associations in England and Norway.                                                                   (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19813111/abstract/Cannabis_use_and_deliberate_s elf_harm_in_adolescence:_a_comparative_analysis_of_associations_in_England_and_Norway_

 

Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.                                                           (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19891810/full_citation/Opposite_relationships_bet  ween_cannabis_use_and_neurocognitive_functioning_in_bipolar_disorder_and_schizophrenia_

 

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania                                         (abst – 2009)  http://jop.sagepub.com/content/25/2/274.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=c  annabinoid&searchid=1&FIRSTINDEX=320&sortspec=date&resourcetype=HWCIT

 

Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.           (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19440079/abstract/Synthetic_delta_9_tetrahydroca  nnabinol__dronabinol__can_improve_the_symptoms_of_schizophrenia_

 

Can recreational doses of THC produce significant dopamine release in the human striatum?        (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19539765/full_citation/Can_recreational_doses_of

_THC_produce_significant_dopamine_release_in_the_human_striatum

 

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.                                                    (abst – 2009)    http://www.ncbi.nlm.nih.gov/pubmed/19560900

 

If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.

(abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19832786/full_citation/If_cannabis_caused_schizo   phrenia_how_many_cannabis_users_may_need_to_be_prevented_in_order_to_prevent_one_case_of_schiz  ophrenia_England_and_Wales_calculations_

 

Minimal Relationship Between Cannabis And Schizophrenia Or Psychosis, Suggested By New Study    (news – 2009)                       http://www.sciencedaily.com/releases/2009/10/091022101538.htm

 

Schizophrenia link to cannabis denied               (news – 2009)  http://www.thisisstaffordshire.co.uk/news/Schizophrenia-link-cannabis-denied/article-1288926-  detail/article.html

 

Cannabis and smoking gene links to schizophrenia ‘unfounded’               (news – 2009)

http://tribes.tribe.net/depressionhelp/thread/101509b4-228a-498e-aec6-db5e2f536398

 

New study suggests minimal relationship between cannabis and schizophrenia or psychosis          (news – 2009)                              http://www.physorg.com/news175425054.html

 

Science: The development of the number of new schizophrenia cases in the UK does not support the hypothesis that cannabis use increases schizophrenia risk                                                               (news – 2009)  http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=299

 

THC can improve symptoms of schizophrenia                (news – 2009)

http://www.cannabis-med.org/index.php?tpl=cannabinoids&id=233&lng=en&red=cannabinoidslist

 

Maternal Marijuana use not Associated with Psychotic Symptoms , but Alcohol is. (news – 2009)  http://ohiopatientsnetwork.org/index.php?option=com_content&view=article&id=85:marijuana-not-  associated-with-psychotic-symptoms-but-alcohol-is&catid=3:newsflash

 

Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia                                                        (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez

 

Reasons for illicit drug use in people with schizophrenia: Qualitative study (full – 2010)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999587/?tool=pubmed

 

Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.                                           (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed

 

Therapeutical use of the cannabinoids in psychiatry                (full – 2010)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-  44462010000500009&lng=en&nrm=iso&tlng=en

 

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.                                                    (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed

 

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders      (full – 2010)                            http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full

 

Endocannabinoids and Schizophrenia                 (link to PDF– 2010)

http://www.mdpi.com/1424-8247/3/10/3101

 

Tardive Dystonia and the Use of Cannabis                (letter – 2010)

http://www.turkpsikiyatri.com/en/default.aspx?modul=article&id=749

 

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.                                                             (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/19785914/abstract/A_behavioural_comparison_of_ acute_and_chronic_Delta9_tetrahydrocannabinol_and_cannabidiol_in_C57BL/6JArc_mice_

 

Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.       (abst – 2010)                     http://www.ncbi.nlm.nih.gov/pubmed/19854030

 

Brain cannabinoid CB2 receptor in schizophrenia.              (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/19931854

 

Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study.           (abst – 2010)                        http://www.ncbi.nlm.nih.gov/pubmed?term=20851843

 

The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample.

(abst – 2010)                    http://www.ncbi.nlm.nih.gov/pubmed/20660494

 

Attraction to cannabis among men with schizophrenia: a phenomenological study.

(abst – 2010)                 http://www.ncbi.nlm.nih.gov/pubmed/20420097

 

Oral THC Reduces Aggressive Behavior In Patients With Refractory Psychosis, Study Says        (news – 2010)                          http://www.norml.org/index.cfm?Group_ID=8419

 

Risk of suicide spurs rimonabant trial to end.                (news – 2010)

http://www.thefreelibrary.com/Risk+of+suicide+spurs+rimonabant+trial+to+end.-a0238838571

 

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice          (full – 2011)                        http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html

 

Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.                                                            (full – 2011)  http://www.ajop.co.za/Journals/November2010/Original%20articles/Cannabis%20use.pdf

 

Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use                                                                     (full – 2011)  http://www.hindawi.com/journals/sprt/2011/501726/

 

Gadolinium-HU-308-incorporated micelles.                (full – 2011)

http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Cannabis, COMT and psychotic experiences.              (full – 2011)

http://bjp.rcpsych.org/content/199/5/380.long

 

Synthetic cannabinoid JWH-018 and psychosis: An explorative study.               (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21316162/abstract/Synthetic_cannabinoid_JWH_0 18_and_psychosis:_An_explorative_study_

 

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. (abst – 2011)                                        http://www.ncbi.nlm.nih.gov/pubmed/21278728

 

Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.                                                  (abst – 2011)        http://www.ncbi.nlm.nih.gov/pubmed/21087649

 

Endocannabinoid system dysfunction in mood and related disorders.           (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21916860

 

Cannabis with high cannabidiol content is associated with fewer psychotic experiences. (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/21592732

 

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.                                                                                   (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21798112

 

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors.        (abst – 2011)                                                       http://www.ncbi.nlm.nih.gov/pubmed/21887137

 

History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.                                                (abst – 2011)       http://www.ncbi.nlm.nih.gov/pubmed/21890594

 

Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?                                               (abst – 2011)        http://www.ncbi.nlm.nih.gov/pubmed/21926420

 

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.    (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/20701826/abstract/The_schizophrenia_susceptibilit y_gene_neuregulin_1_modulates_tolerance_to_the_effects_of_cannabinoids_

 

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.                                                        (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/22007164/abstract/Endocannabinoid_system_and_ psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_

 

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.                                                        (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21693551/abstract/The_endocannabinoid_system_i n_the_regulation_of_emotions_throughout_lifespan:_a_discussion_on_therapeutic_perspectives_

 

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.                                                  (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21420833

 

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannab

 

 

 

Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/21430651

 

Marijuana Use Associated With ‘Superior’ Cognitive Performance In Schizophrenic Patients, Study Says                                                (news – 2011)        http://www.norml.org/index.cfm?Group_ID=8537

 

A Brain Wrought Without Omega-3                (news – 2011)

http://www.schizophreniaforum.org/new/detail.asp?id=1646

 

Debunking the Myth of a Link Between Marijuana and Mental Illness             (news – 2011)

http://www.alternet.org/drugs/151776

 

COMT; another “wrong” result for the reefer madness hype.               (news – 2011)

http://ukcia.org/wordpress/?p=924

 

The Link Between Marijuana and Schizophrenia                (news – 2011)

http://www.time.com/time/health/article/0,8599,2005559,00.html

 

Why Omega-3s Affect Your Mood                (news – 2011)

http://voices.yahoo.com/why-omega-3s-affect-mood-8180941.html?cat=5

 

Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.                                                                       (full – 2012)  http://easap.asia/journal_file/1201_V22N1_p31.pdf

 

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.           (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed

 

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia.                                                            (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/

 

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity                                                           (full – 2012)  http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html

 

The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012)                                      http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full

 

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?               (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1002/dta.1425/full

 

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.                                                     (abst  – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/23108553

 

Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. (abst – 2012)                                    http://www.ncbi.nlm.nih.gov/pubmed/22296986

 

Cortical basket cell dysfunction in schizophrenia.              (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22219337

 

Increased gray matter density in patients with schizophrenia and cannabis use: A voxel- based morphometric study using DARTEL.                                                          (abst – 2012)  http://www.sciencedirect.com/science/article/pii/S0920996412001740

 

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?                                              (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/22625422

 

A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers.                                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22687521

 

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia.                                                   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22716146

 

A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation.     (abst – 2012)                             http://www.ncbi.nlm.nih.gov/pubmed/22716160

 

Neurocognitive functioning and cannabis use in schizophrenia.               (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22716156

 

Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research.                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22716155

 

Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.     (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/22595870

 

Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. (abst – 2012)  http://www.springerlink.com/content/ur5784gm34782505/

 

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.                                                    (abst – 2012)      http://www.ncbi.nlm.nih.gov/pubmed/22903392

 

Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia.                                                 (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22920733

 

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.                                              (abst – 2012)          http://www.ncbi.nlm.nih.gov/pubmed/23042808

 

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult                                            (abst – 2012)  http://www.safetylit.org/citations/index.php?fuseaction=citations.viewdetails&citationIds[]=citjournalarticl e_374483_1

 

Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia                                                          (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22910406

 

Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news – 2012)  http://www.alternet.org/story/155657/study%3A_marijuana_linked_to_lower_mortality_rate_for_patients_  with_psychotic_disorders

 

Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012)                                                http://www.mhhub.com/archives/16603

 

Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation.    (abst – 2013)                                              http://www.ncbi.nlm.nih.gov/pubmed/23359015

 

Cannabis and psychosis: what causes what?                     (abst – 2013)

http://www.ncbi.nlm.nih.gov/pubmed/23361396

 

Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population.                                                                     (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23361397

 

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats                                                             (abst – 2013)

http://link.springer.com/article/10.1007/s00213-012-2839-1

 

Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat.                                                                         (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23389966

Share a link for